Navigation Links
Allergy Drug May Speed Up Kids' Ability to Tolerate Milk

MONDAY, March 21 (HealthDay News) -- Kids who are allergic to milk may be able to quickly develop tolerance by coupling the allergy medication Xolair with a gradual increase in their exposure to milk, known as sensitization, a new study suggests.

An estimated 3 million children in the United States are allergic to some kind of food. Milk allergy is the most common food allergy among children, affecting about 2.5 percent of those younger than 3.

Treatment based on sensitization alone -- exposing children to small but progressively greater amounts of the food substance to which they're allergic -- is often successful. But it's usually a slow process that runs the risk of provoking allergic reactions.

Seeking a faster and safer method, the research team tested a dual approach -- sensitization along with Xolair (omalizumab), a drug that blocks the action of IgE, a natural substance in the body that causes allergic reactions -- in a small group of children. Their findings were to be presented Monday in San Francisco at the annual meeting of the American Academy of Allergy, Asthma and Immunology.

Experts note that research presented at meetings should be considered preliminary because it has not been subjected to the rigorous scrutiny given to research published in medical journals.

Treating milk allergies "could change a child's lifestyle for the better," Dr. Dale Umetsu, a pediatrics professor at Harvard Medical School and Children's Hospital Boston and a co-author of the study, said in a news release from the Stanford University School of Medicine, which also participated in the research. "These children had significant milk allergy, and were unlikely to outgrow it without some type of treatment."

"While we recognize that larger trials are necessary, these results are very promising and suggest that a rapid and safe method of food desensitization might be available for patients in the near future," Umetsu said.

For the study, the children were first given injections of Xolair. Over the next seven to 10 weeks, they were exposed to incrementally increasing amounts of milk, while continuing treatment with the drug. Then, the medication was stopped but the desensitization -- in the form of drinking about two ounces of milk a day -- continued for another eight weeks.

The researchers noted that all of the children completed the full treatment process, which they attributed to adding an allergy medication to the desensitization regimen. The drug acts as a "protective blanket," Dr. Kari Nadeau, an allergist and assistant professor of pediatrics at Stanford and a study co-author, said in the news release.

"Without this treatment, 10 to 20 percent of people who start oral immunotherapy drop out, in part due to intolerable allergic reactions early in the treatment," he said.

At the end of treatment, nine of the eleven children could consume up to 12 ounces of dairy products a day with little or no difficulty, the study found.

"When you try to go on a diet that is completely free of milk, it is very difficult because many foods have a little bit of milk protein in them," Nadeau noted. "From a practical standpoint, this treatment allowed these patients to increase all types of milk products in their diets: They were able to eat yogurt, cheese, bread, a muffin. One patient in our study said, 'I can finally eat goldfish crackers.'"

Dr. Jonathan Field, director emeritus of the pediatric allergy immunology clinic at New York University School of Medicine/Bellevue Medical Center in New York City, described the findings as both "interesting" and "encouraging."

"The caveat is that so far Xolair hasn't been approved for children under 12," he noted. "But immunologically, it makes sense. And this method may promote a safer food desensitization process, which can sometimes entail risk. So anything that can make it a safer process would be quite welcome."

More information

The Nemours Foundation has more on milk allergy in children.

-- Alan Mozes

SOURCES: Jonathan Field, M.D., director emeritus, pediatric allergy/immunology clinic, New York University School of Medicine/Bellevue Medical Center, New York City; news release, Stanford University School of Medicine, March 21, 2011

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Allegheny General Hospital Study Demonstrates Safety and Potential Efficacy of Oral Allergy Treatment
2. Launches Features to Customize Allergy Information - Top Allergy Web Site Provides ZIP-specific Allergy Information and Diary to Track Symptoms
3. NIAID media tip sheet: Annual Meeting of the American Academy of Allergy, Asthma and Immunology
4. Penicillin Allergy Might Not Include Related Antibiotic
5. News tips from the 2010 Annual Meeting of the American Academy of Allergy, Asthma and Immunology
6. Global Warming Kicks Up Allergy Storm
7. New Allergy Testing Available for Patients Allergic to Penicillin: Determining the Presence of Penicillin Allergy is Essential to Patient Care
8. NIAID media availability: Food allergy-related disorder linked to master allergy gene
9. TechWorld Medicals NasalCare Nasal Cleanse Kit Named “Best New Product” at ECRM Cough & Cold and Allergy Conference
10. Irelands Allergy Standards Limited Adds LG Electronics to Host of Companies Making Allergy-Certified Consumer Products
11. Allergy Relief, Chiropractic and Biofeedback Provided at New Absolute Health Clinic in Scottsdale, Arizona
Post Your Comments:
Related Image:
Allergy Drug May Speed Up Kids' Ability to Tolerate Milk
(Date:11/26/2015)... ... November 26, 2015 , ... ... for mental health and wellness consultation, has collaborated with Women’s Web – ... their reader’s queries on topics on mental and emotional well-being relationship, life ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... where preparing the perfect dish and pleasing the palates of attendees is of ... bringing a dish to a seasonal get-together, give these recipes a try this ...
(Date:11/25/2015)... ... November 25, 2015 , ... Dr. John Pierce, Medical Director ... about hair loss treatment with the Capillus272™ Pro laser therapy cap. FDA cleared for ... and fuller hair, without the need for surgery, prescription pills, or topical foams. ...
(Date:11/25/2015)... ... November 25, 2015 , ... According to an article published November ... more widely heralded as a breakthrough for performing hernia repairs. The article explains that ... surgery is that it can greatly reduce the pain that a patient might otherwise ...
(Date:11/25/2015)... Raton, Florida (PRWEB) , ... November 25, 2015 ... ... diagnostic testing for physicians and athletic programs, launches new Wimbledon Athletics ... importance of testing young athletes for unsuspected cardiac abnormalities. About 2,000 people under ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , Nov. 25, 2015  Amgen (NASDAQ: ... License Application (BLA) with the United States ... ABP 501, a biosimilar candidate to Humira ® ... biosimilar application submitted to the FDA and represents Amgen,s ... Sean E. Harper , M.D., executive vice president ...
(Date:11/25/2015)... , Nov. 25, 2015  Linden Care, LLC, ... optimizing treatment outcomes for patients suffering from chronic pain, ... for a Temporary Restraining Order (TRO) enjoining Express Scripts ... two companies. --> --> ... all of its legal options. --> ...
(Date:11/25/2015)... 25, 2015 On Tuesday, November 24, ... trial against Wright Medical Technology, Inc. for product ... metal-on-metal hip implant device, awarded $11 million in ... week trial and three days of deliberations, the ... was defectively designed and unreasonably dangerous, and that ...
Breaking Medicine Technology: